Bruker Corporation (BRKR) vs Vaxcyte, Inc. (PCVX)
A side-by-side comparison of Bruker Corporation and Vaxcyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BRKR
Bruker Corporation
$60.56HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
PCVX
Vaxcyte, Inc.
$65.10HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
Total return — BRKR vs PCVX
growth of $100 · dividends reinvested · last 6yBRKR +55.4% (+7.6%/yr)PCVX +182.3% (+18.9%/yr)PCVX compounded faster over this window
BRKR PCVX
BRKR vs PCVX: by the numbers
- •PCVX is the larger company ($9.40B vs $9.22B market cap).
- •Both run net losses; PCVX's is the smaller (0.00% vs -2.03% net margin).
- •BRKR pays a dividend (0.23% yield), while PCVX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BRKR | PCVX |
|---|---|---|
| Forward P/E | 28.54 | N/A |
| P/S ratio | 2.63 | N/A |
| P/B ratio | 3.84 | 3.41 |
| EV / EBITDA | 30.70 | N/A |
| FCF yield | 1.02% | N/A |
Profitability
| Metric | BRKR | PCVX |
|---|---|---|
| Gross margin | 46.69% | 0.00% |
| Operating margin | 3.61% | 0.00% |
| Net margin | -2.03% | 0.00% |
| ROE | -2.97% | -38.59% |
| ROIC | 2.56% | -40.65% |
Dividends
| Metric | BRKR | PCVX |
|---|---|---|
| Dividend yield | 0.23% | N/A |
Growth (annualized)
| Metric | BRKR | PCVX |
|---|---|---|
| Revenue CAGR (5Y) | 9.10% | N/A |
| FCF CAGR (5Y) | -21.33% | N/A |
| Total return CAGR (5Y) | -3.42% | 25.08% |
Frequently asked
- Does BRKR or PCVX pay a bigger dividend?
- BRKR pays a dividend (0.23% yield), while PCVX has no payments in the available dividend history.
- How have BRKR and PCVX total returns compared?
- Over the past 5 years, BRKR delivered -3.42% and PCVX delivered 25.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.